Emergent BioSolutions (EBS) Tops Q4 EPS by 13c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $6.80 -3.13%
Revenue Growth %: -45.6%
Financial Fact:
Earnings per share - diluted: 0.45
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: -45.6%
Financial Fact:
Earnings per share - diluted: 0.45
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q4 EPS of $0.75, $0.13 better than the analyst estimate of $0.62. Revenue for the quarter came in at $270.7 million versus the consensus estimate of $270.03 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Barclays says AI trade is maturing, favors greater diversification
- Circle Internet stock climbs on TD Cowen upgrade, Fed rate hike
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
